FIU20020420U0 - Tamsulosiinin sulfonaattisuolalla diastereomerisesti rikastettu sakka tai liuos joka aikaansaadaan menetelmällä tamsulosiinin ja siihen liittyvien yhdisteiden liuottamisella - Google Patents
Tamsulosiinin sulfonaattisuolalla diastereomerisesti rikastettu sakka tai liuos joka aikaansaadaan menetelmällä tamsulosiinin ja siihen liittyvien yhdisteiden liuottamisellaInfo
- Publication number
- FIU20020420U0 FIU20020420U0 FI20020420U FIU20020420U FIU20020420U0 FI U20020420 U0 FIU20020420 U0 FI U20020420U0 FI 20020420 U FI20020420 U FI 20020420U FI U20020420 U FIU20020420 U FI U20020420U FI U20020420 U0 FIU20020420 U0 FI U20020420U0
- Authority
- FI
- Finland
- Prior art keywords
- tamsulosin
- suflonate
- bind
- precipitation
- salt
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
- C07C217/14—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring
- C07C217/18—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
- C07C217/20—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by halogen atoms, by trihalomethyl, nitro or nitroso groups, or by singly-bound oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
- C07C303/42—Separation; Purification; Stabilisation; Use of additives
- C07C303/44—Separation; Purification
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/37—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33081701P | 2001-10-31 | 2001-10-31 | |
| US10/208,009 US6835853B2 (en) | 2001-10-31 | 2002-07-31 | Process for resolution of tamsulosin and compounds, compositions, and processes associated therewith |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FIU20020420U0 true FIU20020420U0 (fi) | 2002-10-23 |
| FI5957U1 FI5957U1 (fi) | 2003-09-30 |
Family
ID=26902810
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI20020421U FI5816U1 (fi) | 2001-10-31 | 2002-10-23 | Raseeminen tamsulosiinivapaa emäs |
| FI20020420U FI5957U1 (fi) | 2001-10-31 | 2002-10-23 | Tamsulosiinin sulfonaattisuolalla diastereomerisesti rikastettu sakka tai liuos joka aikaansaadaan menetelmällä tamsulosiinin ja siihen liittyvien yhdisteiden liuottamisella |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI20020421U FI5816U1 (fi) | 2001-10-31 | 2002-10-23 | Raseeminen tamsulosiinivapaa emäs |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US6835853B2 (fi) |
| EP (2) | EP1444198A1 (fi) |
| CN (2) | CN100343227C (fi) |
| AT (2) | ATE417822T1 (fi) |
| AU (2) | AU2002330774B9 (fi) |
| CA (2) | CA2464648C (fi) |
| CH (3) | CH697034A5 (fi) |
| CZ (2) | CZ13580U1 (fi) |
| DE (3) | DE60230438D1 (fi) |
| DK (2) | DK200200339U3 (fi) |
| FI (2) | FI5816U1 (fi) |
| FR (2) | FR2832147B1 (fi) |
| IL (2) | IL161449A0 (fi) |
| IS (2) | IS6603A (fi) |
| NL (2) | NL1021671C2 (fi) |
| NO (1) | NO20042256L (fi) |
| WO (2) | WO2003037850A1 (fi) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2200699B1 (es) * | 2002-07-12 | 2005-10-01 | Ragactives, S.L | Procedimiento para la separacion de r(-) y s(+)-5-(2-((2-(etoxifenoxi)etil)amino)propil-2-metoxibenceno-sulfonamida. |
| USH2154H1 (en) * | 2003-10-08 | 2006-04-04 | Farmak, A.S. | Process for preparing R- and S-isomers of (R)-5-(2-( (2-(2-ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide |
| SI21656A (sl) * | 2003-12-29 | 2005-06-30 | LEK farmacevtska družba d.d. | Priprava (R)-5-(2-(2-(2-etoksifenoksi) etilamino)-1-propil)-2-metoksibenzensulfonamida hidroklorida z visoko kemijsko čistoto |
| SI21702A (en) * | 2004-01-29 | 2005-08-31 | Lek Farmacevtska Druzba Dd | Preparation of amorphous form of tamsulosin |
| WO2005089511A2 (en) * | 2004-03-19 | 2005-09-29 | Transform Pharmaceuticals, Inc. | Novel pharmaceutical forms, and methods of making and using the same |
| CN100545148C (zh) | 2004-08-16 | 2009-09-30 | 神隆新加坡私人有限公司 | 一种抗良性前列腺肥大药物坦索罗辛之合成方法 |
| US7238839B2 (en) | 2004-10-07 | 2007-07-03 | Divi's Laboratories Limited | Process for the resolution of racemic (R,S) -5-(2-(2-(2- ethoxyphenoxy) ethylamino)Propyl)-2-methoxybenzene sulfonamide (tamsulosin), its novel R and S isomers and their salts and processes for their preparation |
| PT103216B (pt) | 2004-12-06 | 2010-05-19 | Hovione Farmaciencia S A | Preparação de tamsulosin |
| WO2006117662A2 (en) * | 2005-05-03 | 2006-11-09 | Ranbaxy Laboratories Limited | Polymorphic forms of (r)-(-)-tamsulosin |
| WO2006134212A2 (en) * | 2005-06-15 | 2006-12-21 | Fermion Oy | Preparation of tamsulosin hydrochloride from tamsulosi |
| EP2026766A1 (en) | 2006-05-17 | 2009-02-25 | Synthon B.V. | Tablet composition with a prolonged release of tamsulosin |
| US20080312328A1 (en) * | 2007-06-14 | 2008-12-18 | Protia, Llc | Deuterium-enriched tamsulosin |
| DE102008002409A1 (de) * | 2008-06-13 | 2009-12-17 | Evonik Goldschmidt Gmbh | Enzymatische Synthese von Sphingolipiden |
| US8465770B2 (en) * | 2008-12-24 | 2013-06-18 | Synthon Bv | Low dose controlled release tablet |
| EP2338876A1 (en) | 2009-12-22 | 2011-06-29 | LEK Pharmaceuticals d.d. | Tamsulosin adipate for pharmaceutical use |
| KR101525493B1 (ko) * | 2013-01-02 | 2015-06-03 | 보령제약 주식회사 | 고순도 탐술로신 또는 이의 염 제조방법 |
| CN104926699B (zh) * | 2015-07-02 | 2018-09-25 | 成都丽凯手性技术有限公司 | 一种高光学纯度盐酸坦索罗辛的制备方法 |
| CN106631918B (zh) * | 2016-10-13 | 2018-07-13 | 深圳万和制药有限公司 | 拆分坦索罗辛对映异构体的方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH383998A (de) * | 1959-08-05 | 1964-11-15 | Ciba Geigy | Verfahren zur Herstellung neuer sekundärer Amine |
| US3412154A (en) * | 1964-08-12 | 1968-11-19 | Parke Davis & Co | Amino-substituted phenone compounds |
| CA1147342A (en) | 1977-10-12 | 1983-05-31 | Kazuo Imai | Process of producing novel phenylethanolamine derivatives |
| JPS56110665A (en) | 1980-02-08 | 1981-09-01 | Yamanouchi Pharmaceut Co Ltd | Sulfamoyl-substituted phenetylamine derivative and its preparation |
| US5391825A (en) * | 1980-02-08 | 1995-02-21 | Yamanouchi Pharmaceutical Co., Ltd. | Sulfamoyl substituted phenethylamine intermediates |
| JPH066565B2 (ja) | 1986-07-21 | 1994-01-26 | 山之内製薬株式会社 | 光学活性なベンゼンスルホンアミド誘導体の製造法 |
| ES2098069T3 (es) * | 1993-02-23 | 1997-04-16 | Hoechst Ag | Bencenosulfonil-ureas y -tioureas sustituidas, procedimiento para su preparacion y su utilizacion como agentes farmaceuticos. |
| US5877218A (en) * | 1994-01-10 | 1999-03-02 | Teva Pharmaceutical Industries, Ltd. | Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives |
-
2002
- 2002-07-31 US US10/208,009 patent/US6835853B2/en not_active Expired - Fee Related
- 2002-10-15 CA CA002464648A patent/CA2464648C/en not_active Expired - Fee Related
- 2002-10-15 EP EP02768172A patent/EP1444198A1/en not_active Withdrawn
- 2002-10-15 IL IL16144902A patent/IL161449A0/xx unknown
- 2002-10-15 CN CNB02821644XA patent/CN100343227C/zh not_active Expired - Fee Related
- 2002-10-15 AU AU2002330774A patent/AU2002330774B9/en not_active Ceased
- 2002-10-15 WO PCT/NL2002/000657 patent/WO2003037850A1/en not_active Application Discontinuation
- 2002-10-16 NL NL1021671A patent/NL1021671C2/nl not_active IP Right Cessation
- 2002-10-17 DE DE60230438T patent/DE60230438D1/de not_active Expired - Lifetime
- 2002-10-17 AU AU2002330776A patent/AU2002330776B2/en not_active Ceased
- 2002-10-17 AT AT02768175T patent/ATE417822T1/de not_active IP Right Cessation
- 2002-10-17 CA CA002464917A patent/CA2464917C/en not_active Expired - Fee Related
- 2002-10-17 CN CN02821733A patent/CN100579958C/zh not_active Expired - Fee Related
- 2002-10-17 EP EP02768175A patent/EP1444199B1/en not_active Expired - Lifetime
- 2002-10-17 WO PCT/NL2002/000660 patent/WO2003037851A1/en not_active Application Discontinuation
- 2002-10-17 NL NL1021678A patent/NL1021678C2/nl not_active IP Right Cessation
- 2002-10-17 IL IL16149002A patent/IL161490A0/xx unknown
- 2002-10-23 FI FI20020421U patent/FI5816U1/fi active
- 2002-10-23 FI FI20020420U patent/FI5957U1/fi active
- 2002-10-24 AT AT0071102U patent/AT6687U1/de not_active IP Right Cessation
- 2002-10-25 CZ CZ200213601U patent/CZ13580U1/cs not_active IP Right Cessation
- 2002-10-25 CZ CZ200213600U patent/CZ13392U1/cs not_active IP Right Cessation
- 2002-10-30 DK DK200200339U patent/DK200200339U3/da not_active IP Right Cessation
- 2002-10-30 CH CH02083/06A patent/CH697034A5/de not_active IP Right Cessation
- 2002-10-30 IS IS6603A patent/IS6603A/is unknown
- 2002-10-30 DK DK200200338U patent/DK200200338U3/da not_active IP Right Cessation
- 2002-10-30 IS IS6602A patent/IS6602A/is unknown
- 2002-10-30 CH CH01827/02A patent/CH697164A5/de not_active IP Right Cessation
- 2002-10-31 FR FR0213668A patent/FR2832147B1/fr not_active Expired - Fee Related
- 2002-10-31 DE DE20216779U patent/DE20216779U1/de not_active Expired - Lifetime
- 2002-10-31 DE DE20216835U patent/DE20216835U1/de not_active Expired - Lifetime
- 2002-10-31 FR FR0213667A patent/FR2832146B1/fr not_active Expired - Fee Related
- 2002-10-31 CH CH01848/02A patent/CH696665A5/de not_active IP Right Cessation
-
2004
- 2004-06-01 NO NO20042256A patent/NO20042256L/no not_active Application Discontinuation
- 2004-11-15 US US10/987,111 patent/US6965051B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FIU20020420U0 (fi) | Tamsulosiinin sulfonaattisuolalla diastereomerisesti rikastettu sakka tai liuos joka aikaansaadaan menetelmällä tamsulosiinin ja siihen liittyvien yhdisteiden liuottamisella | |
| NO2018037I1 (no) | Simeprevir, eller salt derav, innbefattende natrium-simeprevir | |
| NO2014011I1 (no) | Vortioksetin eller et farmasøytisk akseptabelt syreaddisjonssalt dera | |
| PL1718675T3 (pl) | Sposób uzyskiwania oczyszczonego preparatu przeciwciał pozbawionego wirusów | |
| JP2008506632A5 (fi) | ||
| NO2016003I2 (no) | Pasireotid eller et farmasøytisk akseptabelt salt derav eller et hvilket som helst hydrat derav | |
| DE60238651D1 (de) | Wiederherstellung einer Prozesskassette | |
| DK1252170T4 (da) | Selektiv krystallisation af 3-pyridyl-1-hydroxyethyliden-1,1-bisphosphonsyrenatrium som hemipentahydrat eller monohydrat | |
| IS7755A (is) | Aðferð við framleiðslu á (S,S)-cis-2-benshýdríl-3-bensýlamínókínuklídín | |
| JP2008513472A5 (fi) | ||
| EP2213674A4 (en) | CLEANING PROCEDURE FOR PEMETREXED SALTS, SODIUM SALT AND SODIUM SALT | |
| DK1592401T3 (da) | Fremgangsmåde til ændring af medikamentkrystaldannelsen af mycophenolat-natriumsalt | |
| DE602004031907D1 (de) | Verfahren zur Herstellung von Nanopartikeln durch grössenspezifische Photoätzung | |
| DE60114468D1 (de) | Optimierung der herstellung von polycarbonat durch umesterung | |
| CY1117753T1 (el) | Κρυσταλλικη μορφη του αλατος αργινινης της περινδοπριλης, μεθοδος παρασκευης της και φαρμακευτικες συνθεσεις οι οποιες την περιεχουν | |
| DK1385826T3 (da) | Fremgangsmåde til fremstilling af (S)-(+)- og (R)-(-)-10,11-dihydro-10-hydroxy-5H-dibenz/b,f/azapin-5-carboxamid | |
| DK1348445T3 (da) | Fremgangsmåde til separering af vira fra en proteinopløsning ved nano-filtrering | |
| DK1456281T3 (da) | Fremgangsmåde til genvinding af en polymer fra en oplösning | |
| DK1536685T4 (da) | Fremgangsmåde til fremstilling af pasta-ekstruderede sulfonamidsammensætninger | |
| WO2005012271A3 (en) | Process for the synthesis of biaryl oxazolidinones | |
| DK1198466T3 (da) | Fremgangsmåde til fremstilling af glyphosater eller et salt deraf | |
| DK1682541T3 (da) | Fremgangsmåde til fremstilling af tiotropiumsalte | |
| DE60238056D1 (de) | Verfahren zum kristallisieren von reduziertem coenzym q10 aus wässriger lösung | |
| NO20054008D0 (no) | Fremgangsmate for a separere NH3 og valgfritt ogsa CO2 og H2O for en blanding som inneholder NH3 CO2 og H2O | |
| DK1505069T3 (da) | Fremgangsmåde til rensning af moxidectin ved hjælp af krystallisation |